Your session is about to expire
← Back to Search
This trial is testing whether or not a numbing drop (tetracaine) is more effective and less painful than a numbing agent applied directly to the eardrum (phenol) for people getting a steroid injection into the ear for Meniere's disease or idiopathic sudden sensorineural hearing loss.
- Intratympanic Steroid Injection
- Sudden Sensorineural Hearing Loss
- Meniere's Disease
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- Your treatment plan involves getting steroid injections in your ear.You have been diagnosed with sudden sensorineural hearing loss or Meniere's disease.You have a hole in your eardrum right now.You must be 18 years old or older to participate.You have been diagnosed with sudden hearing loss or Meniere's disease.Your treatment plan involves getting a steroid injection in your ear.
- Group 1: Tetracaine
- Group 2: Phenol
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What afflictions are commonly treated with Tetracaine?
"Moderate and persistent cases of psoriasis can be managed with tetracaine. The medication may also prove to be beneficial for other ailments, including exanthema, mild throat inflammation, and minor burns."
What is the current enrollment size for this clinical trial?
"Affirmative. Clinicaltrials.gov cites that this medical trial is presently enrolling patients since its initial posting on 8/1/2021, with the latest update occurring on 9/20/2022. The study seeks 80 volunteers from a single location."
Are there precedent studies that have utilized Tetracaine?
"Currently, 5 clinical trials for Tetracaine are being conducted. One of these studies is in the third and final phase. The majority of testing sites are situated in Scottsdale, Arizona; however, there are also 4 other locations where this medication can be tested."
Are there still opportunities for participants to join this experiment?
"The information hosted on clinicaltrials.gov indicates that this trial is still recruiting patients, with the initial post posted on August 1st 2021 and the latest update being made September 20th 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Average response time
- < 2 Days
Most responsive sites:
- Our Lady of the Lake Hospital: < 48 hours
Share this study with friends